Rephco Pharmaceuticals struggles to make up pandemic losses | The Business Standard
Skip to main content
  • Latest
  • Epaper
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Tuesday
June 24, 2025

Sign In
Subscribe
  • Latest
  • Epaper
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
TUESDAY, JUNE 24, 2025
Rephco Pharmaceuticals struggles to make up pandemic losses

Economy

M Jahirul Islam Jewel
29 August, 2021, 10:10 am
Last modified: 29 August, 2021, 11:42 am

Related News

  • Price fixing for cardiac stents logical, no shortage in equipment: DGDA
  • Cardiac stent prices cut by up to 46%
  • DGDA proposes to include lessons about antibiotic resistance in textbooks
  • Unreasonable price hike of medicine unacceptable: Consumers' association
  • Monitor prescriptions, rein in retailing to stop misuse of antibiotics: Experts

Rephco Pharmaceuticals struggles to make up pandemic losses

Sales of the company’s medicine have reduced by 40% to 50% since the beginning of the pandemic in March 2020

M Jahirul Islam Jewel
29 August, 2021, 10:10 am
Last modified: 29 August, 2021, 11:42 am
Rephco Pharmaceuticals struggles to make up pandemic losses

Barishal-based Rephco Pharmaceuticals Limited, one of the oldest pharmaceutical companies in the country, is passing through its worst time since its establishment due to a sharp drop in sales triggered by the ongoing Covid-19 pandemic.

"Our sales have been reduced by 40-50% since the beginning of the pandemic in March 2020," said Jahidul Alom Jewel, director of Rephco Pharmaceuticals and also one of the owners of the firm.

"Due to the repeated lockdowns during the last one and a half years, our medical promotion officers could not visit the doctors and medicine shops regularly, which is the main reason behind the massive drop in sales," he added.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

During the 52 years of its journey, the company has faced different crises, but the owners of the company never compromised with the quality of medicine, according to the Directorate General of Drug Administration (DGDA) office in Barishal.

Barishal DGDA Superintendent Auditi Swarna said Rephco Pharmaceuticals has earned goodwill in the pharmaceutical sector by ensuring the best quality medicine for decades.

She said, "We are satisfied with the product quality of Rephco. In all circumstances they are ensuring the quality of their medicine."

Rephco Pharmaceuticals, established in 1968, became an instant success story by producing quality medicine and distributing it across the country. 

The company was established by the late Khalilur Rahman, who was a wholesale dealer of six medicine companies and owner of a small pharmacy in Barishal city. 

Based on the experience he had gathered as a dealer of medicine companies and owner of a pharmacy, he established the medicine factory at Kownia area in Barishal city, according to Rephco officials.

They said at the beginning that the company had obtained permission to manufacture 12 kinds of liquid syrups. Now the company is producing 92 types of medicine, including tablets and capsules.

"To maintain the standard of medicine, we collect raw materials from the best available sources," said Jahidul Alom Jewel, adding that the firm imports raw materials of antibiotics from Italy, vitamins from Germany and Switzerland, and the raw materials of all other medicine from China.

He said, "We distribute our medicine all across the country through a team of efficient medical promotion officers. We have a workforce of around 1,200 people including the factory workers and officials. The yearly sale of the company is around Tk75 crore to Tk80 crore. Including all imports, the yearly transaction of the company is Tk130 crore to Tk150 crore."

The company is operated by five directors who also hold equal ownership, said Jewel, adding that all their marketing activities are operated from their corporate office in Dhaka.

"The company now has more production capacity than its market demand. So, we are considering exporting our medicine," he added.

Abdus Sattar, who has been involved in the medicine business since 1965 and is the owner of a pharmacy in Jhalokati, said medicines manufactured by Rephco Pharmaceuticals were very popular in the 1970s, 1980s, and early 1990s. 

Though its popularity has declined now, the quality of its medicine is the same as it was in the past, he added.

Top News

Rephco Pharmaceuticals / Directorate General of Drug Administration (DGDA) / Economic Impact of Coronavirus

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • A 3D printed miniature model of US President Donald Trump, Israel and Iran flags are seen in this illustration taken June 18, 2025. Photo: REUTERS/Dado Ruvic/Illustration
    New Israeli strikes on Iran reported despite Trump's command to stop
  • Trump at the South Lawn at the White House. REUTERS/Kevin Lamarque
    Trump 'really unhappy' with Israel after it orders new strikes on Iran
  • IMF approves $1.3b for Bangladesh in 4th, 5th tranches of $4.7b loan
    IMF approves $1.3b for Bangladesh in 4th, 5th tranches of $4.7b loan

MOST VIEWED

  • 'Made in Bangladesh' solar panels go to US for the first time
    'Made in Bangladesh' solar panels go to US for the first time
  • Remittance dollar rate falls amid weak demand, strong export growth
    Remittance dollar rate falls amid weak demand, strong export growth
  • Union Bank branch manager uses multiple schemes to embezzle Tk8cr: Internal probe
    Union Bank branch manager uses multiple schemes to embezzle Tk8cr: Internal probe
  • SBAC Bank faces Tk810.75cr provision shortfall in 2024
    SBAC Bank faces Tk810.75cr provision shortfall in 2024
  • ‘Congratulations world, it’s time for peace’: Trump thanks Iran for ‘early notice’ on attacks
    ‘Congratulations world, it’s time for peace’: Trump thanks Iran for ‘early notice’ on attacks
  • Busbar malfunction caused sudden blackout in parts of Dhaka last night: Power Grid Bangladesh
    Busbar malfunction caused sudden blackout in parts of Dhaka last night: Power Grid Bangladesh

Related News

  • Price fixing for cardiac stents logical, no shortage in equipment: DGDA
  • Cardiac stent prices cut by up to 46%
  • DGDA proposes to include lessons about antibiotic resistance in textbooks
  • Unreasonable price hike of medicine unacceptable: Consumers' association
  • Monitor prescriptions, rein in retailing to stop misuse of antibiotics: Experts

Features

The HerWILL mentorship programme - Cohort 01: A rarity in reach and depth

The HerWILL mentorship programme - Cohort 01: A rarity in reach and depth

1d | Features
Graphics: TBS

Who are the Boinggas?

1d | Panorama
PHOTO: Akif Hamid

Honda City e:HEV debuts in Bangladesh

2d | Wheels
The Jeeps rolled out at the earliest hours of Saturday, 14th June, to drive through Nurjahan Tea Estate and Madhabpur Lake, navigating narrow plantation paths with panoramic views. PHOTO: Saikat Roy

Rain, Hills and the Wilderness: Jeep Bangladesh’s ‘Bunobela’ Run Through Sreemangal

2d | Wheels

More Videos from TBS

Will the Iran-Israel ceasefire take effect?

Will the Iran-Israel ceasefire take effect?

28m | TBS World
ECNEC approves 17 projects worth Tk 8,974 crore

ECNEC approves 17 projects worth Tk 8,974 crore

58m | TBS Today
Trump hints at regime change in Iran; what could the future hold?

Trump hints at regime change in Iran; what could the future hold?

1h | TBS World
Omera Petroleum to acquire Tolatgaz Bangladesh for $32 m

Omera Petroleum to acquire Tolatgaz Bangladesh for $32 m

2h | TBS Insight
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net